ALS

Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness and atrophy. Research has identified genetic factors as significant contributors to ALS, with specific genes and modifiers playing crucial roles in its development. Environmental factors, such as exposure to certain toxins, also appear to interact with genetic predispositions to influence the onset and progression of the disease. Advances in neurophysiological techniques have improved the accuracy of diagnosing ALS, allowing for earlier intervention and better management of symptoms.

The molecular subtypes of ALS, characterized by distinct cellular and pathological features, have been identified through deep multiomics classifiers, offering new insights into personalized treatment approaches. Despite these advancements, the exact mechanisms underlying ALS remain complex and not fully understood. There are currently no known strong connections to other diseases or conditions that directly influence ALS.

The evidence for some of these findings is still evolving, particularly in areas like molecular subtypes and genetic modifiers.

Sources

• [[Amyotrophic lateral sclerosis (ALS) - diagnosis, course of disease and treatment options].](https://pubmed.ncbi.nlm.nih.gov/34879411/) (PMID:34879411)
• Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques. (PMID:31185581)
• The epidemiology of ALS: a conspiracy of genes, environment and time. (PMID:24126629)
• Genetics of ALS - genes and modifier. (PMID:40772638)
• ALS. (PMID:8959992)
• ALS molecular subtypes are a combination of cellular and pathological features learned by deep multiomics classifiers. (PMID:40067829)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._